Literature DB >> 21309857

Training of trainers on epinephrine autoinjector use.

Mustafa Arga1, Arzu Bakirtas, Ferhat Catal, Oksan Derinoz, Koray Harmanci, Cem H Razi, Salih Ergöcen, M Sadik Demirsoy, Ipek Turktas.   

Abstract

The majority of physicians do not know how to use epinephrine autoinjectors. This displays that current education of physicians on anaphylaxis is inadequate for a thorough practice. We hypothesize that a theoretical lecture together with a practical session on epinephrine autoinjector use will improve its proper use by physicians. Residents, specialists, and consultants from General Pediatrics excluding allergists and allergy fellows were included in this study. All physicians were given an eight-item questionnaire followed by a practical session scoring and timing ability to use epinephrine autoinjector trainer. This ensued with one-to-one hands-on training on correct autoinjector use. Finally, a joint theoretical lecture on anaphylaxis including re-demonstration of epinephrine autoinjector use was given. All physicians were scored a second time on use of epinephrine autoinjector 6 months later. One hundred fifty-one of 196 participants completed all steps of the study in four tertiary hospitals. Correct use of epinephrine autoinjector improved from 23.3% to 74.2%, mean score from 3.49 ± 1.14 to 4.66 ± 0.65, need for prospectus from 91.4% to 29.1%, and mean time to administer autoinjector from 28.01 ± 6.22 s to 19.62 ± 5.01 s (p < 0.001 for each). The rate of most common mistakes during autoinjector use decreased but the ranking did not change. An integrated theoretical and practical education increased correct of epinephrine autoinjector use by physicians. Ongoing mistakes despite this education may be related with its design.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309857     DOI: 10.1111/j.1399-3038.2011.01143.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  7 in total

Review 1.  Food-Induced Anaphylaxis: an Update.

Authors:  Christopher P Parrish; Heidi Kim
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-14       Impact factor: 4.806

2.  Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement.

Authors:  Sandra M Salter; Richard Loh; Frank M Sanfilippo; Rhonda M Clifford
Journal:  Allergy Asthma Clin Immunol       Date:  2014-09-19       Impact factor: 3.406

3.  International consensus on (ICON) anaphylaxis.

Authors:  F Estelle R Simons; Ledit Rf Ardusso; M Beatrice Bilò; Victoria Cardona; Motohiro Ebisawa; Yehia M El-Gamal; Phil Lieberman; Richard F Lockey; Antonella Muraro; Graham Roberts; Mario Sanchez-Borges; Aziz Sheikh; Lynette P Shek; Dana V Wallace; Margitta Worm
Journal:  World Allergy Organ J       Date:  2014-05-30       Impact factor: 4.084

4.  Learning and Treatment of Anaphylaxis by Laypeople: A Simulation Study Using Pupilar Technology.

Authors:  Felipe Fernandez-Mendez; Nieves Maria Saez-Gallego; Roberto Barcala-Furelos; Cristian Abelairas-Gomez; Alexis Padron-Cabo; Alexandra Perez-Ferreiros; Carlos Garcia-Magan; Jose Moure-Gonzalez; Onofre Contreras-Jordan; Antonio Rodriguez-Nuñez
Journal:  Biomed Res Int       Date:  2017-07-05       Impact factor: 3.411

Review 5.  Update on the usage and safety of epinephrine auto-injectors, 2017.

Authors:  Larry S Posner; Carlos A Camargo
Journal:  Drug Healthc Patient Saf       Date:  2017-03-21

6.  Improving adrenaline autoinjector adherence: A psychologically informed training for healthcare professionals.

Authors:  Béré Mahoney; Elaine Walklet; Eleanor Bradley; Steve O'Hickey
Journal:  Immun Inflamm Dis       Date:  2019-07-09

7.  A Simple Allergist-Led Intervention Improves Resident Training in Anaphylaxis.

Authors:  Artemio M Jongco; Sheila Bina; Robert J Sporter; Marie A Cavuoto Petrizzo; Blanka Kaplan; Myriam Kline; Susan J Schuval
Journal:  J Allergy (Cairo)       Date:  2016-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.